Paper-Based Platform with an In Situ Molecularly Imprinted Polymer for β-Amyloid.

It is important to highlight that the previously described MIP biosensors, devoted to Aβ-42, may be developed to target other biomarkers circulating in the blood, including Aβ-42 derivatives, most recently established as highly significant in terms of AD. 7 Overall, considering the increasing worldwide incidence of AD, a suitable inexpensive and eco-friendly biosensor with high stability and selectivity is still missing.

also in 132,142 other papers